Cargando…

P1458: MITAPIVAT AMELIORATES IN VITRO HUMAN Β THALASSEMIC ERYTHROID MATURATION INDEX AND MODULATES THE EXPRESSION OF THE CYTOPROTECTOR PEROXIREDOXIN-2.

Detalles Bibliográficos
Autores principales:	Matte’, Alessandro, Huot, Richard Pozzetto, Mattarei, Andrea, Ongaro, Alberto, Passarini, Alice, Siciliano, Angela, Russo, Roberta, Iolascon, Achille, Brugnara, Carlo, De Franceschi, Lucia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430706/ http://dx.doi.org/10.1097/01.HS9.0000972716.20723.c9

Ejemplares similares

Mitapivat, a pyruvate kinase activator, improves transfusion burden and reduces iron overload in β-thalassemic mice
por: Mattè, Alessandro, et al.
Publicado: (2023)

Oxidative Stress and β-Thalassemic Erythroid Cells behind the Molecular Defect
por: De Franceschi, Lucia, et al.
Publicado: (2013)

Mitapivat reprograms the RBC metabolome and improves anemia in a mouse model of hereditary spherocytosis
por: Matte, Alessandro, et al.
Publicado: (2023)

Data demonstrating the role of peroxiredoxin 2 as important anti-oxidant system in lung homeostasis
por: Federti, Enrica, et al.
Publicado: (2017)

Screening of cytoprotectors against methotrexate-induced cytogenotoxicity from bioactive phytochemicals
por: Gu, Shaobin, et al.
Publicado: (2016)

5613423 TREATMENT OF ERYTHROID PRECURSOR CELLS FROM β-THALASSEMIC PATIENTS WITH ISOXAZOLE DERIVATIVES: POTENT INDUCTION OF FETAL HEMOGLOBIN
por: Cristina Zuccato, C.Z., et al.
Publicado: (2023)

Plasma peroxiredoxin changes and inflammatory cytokines support the involvement of neuro-inflammation and oxidative stress in Autism Spectrum Disorder
por: Abruzzo, P. M., et al.
Publicado: (2019)

Ca(2+)-Dependent Effects of the Selenium-Sorafenib Nanocomplex on Glioblastoma Cells and Astrocytes of the Cerebral Cortex: Anticancer Agent and Cytoprotector
por: Varlamova, Elena G., et al.
Publicado: (2023)

1,4,5,8-Tetraisopropylanthracene
por: Kitamura, Chitoshi, et al.
Publicado: (2010)

The role of P-wave dispersion in dystrophic and thalassemic cardiomyopathy
por: Russo, Vincenzo, et al.
Publicado: (2017)

Right in time: Mitapivat for the treatment of anemia in α- and β-thalassemia
por: Musallam, Khaled M., et al.
Publicado: (2022)

Treating pyruvate kinase deficiency with Mitapivat: a short communication
por: Larik, Muhammad Omar, et al.
Publicado: (2023)

1,4,5,8-Tetra-n-butylanthracene
por: Kitamura, Chitoshi, et al.
Publicado: (2010)

Tyrosine Phosphorylation Modulates Peroxiredoxin-2 Activity in Normal and Diseased Red Cells
por: Mattè, Alessandro, et al.
Publicado: (2021)

Elevated CDKN1A (P21) mediates β-thalassemia erythroid apoptosis, but its loss does not improve β-thalassemic erythropoiesis
por: Liang, Raymond, et al.
Publicado: (2023)

In Humanized Sickle Cell Mice, Imatinib Protects Against Sickle Cell–Related Injury
por: Federti, Enrica, et al.
Publicado: (2023)

Desferioximine induced Ototoxicity in Thalassemic patients
por: Vir, Dharam, et al.
Publicado: (2010)

Mitapivat, a novel pyruvate kinase activator, for the treatment of hereditary hemolytic anemias
por: Al-Samkari, Hanny, et al.
Publicado: (2021)

The Antioxidant Effect of Erythropoietin on Thalassemic Blood Cells
por: Amer, Johnny, et al.
Publicado: (2010)

The Reproductive Behavior of Families with Thalassemic Children in Hormozgan
por: Safari Moradabadi, Ali, et al.
Publicado: (2015)

Outcome of iron reduction therapy in ex-thalassemics
por: Aboobacker, Fouzia N., et al.
Publicado: (2021)

Perception of Parents of Thalassemic Child to Thalassemia in Pakistan
por: Saleem, Noman, et al.
Publicado: (2021)

Enhancement of β‐Globin Gene Expression in Thalassemic IVS2‐654 Induced Pluripotent Stem Cell‐Derived Erythroid Cells by Modified U7 snRNA
por: Phanthong, Phetcharat, et al.
Publicado: (2017)

OPC Server and BridgeView Application for High Voltage Power Supply Lecroy 1458
por: Swoboda, D, et al.
Publicado: (2000)

Synthesis of Salts of 1,2,5,6- and 1,4,5,8-Naphthalenetetramine
por: Langis-Barsetti, Sophie, et al.
Publicado: (2017)

P1586: COMPARISON OF FREQUENCY OF TRANSFUSION RELATED COMPLICATIONS IN THALASSEMIC AND NON-THALASSEMIC PATIENTS RECEIVING NON LEUKODEPLETED RED CELL CONCENTRATE.
por: Imran, Tanzeel, et al.
Publicado: (2023)

Factors regulating Hb F synthesis in thalassemic diseases
por: Mastropietro, Fabrizio, et al.
Publicado: (2002)

Study of behavioral problems in multi-transfused thalassemic children
por: Hongally, Chandrashekar, et al.
Publicado: (2012)

Iron deposits in the knee joints of a thalassemic patient
por: Economides, Charalambos P, et al.
Publicado: (2012)

Direct antiglobulin test positivity in multi-transfused thalassemics
por: Jain, Ashish, et al.
Publicado: (2016)

Thalassemic Child Presenting with Anosmia due to COVID-19
por: Marhaeni, Wulandewi, et al.
Publicado: (2020)

Growth pattern in thalassemic children and their correlation with serum ferritin
por: Rathaur, Vyas Kumar, et al.
Publicado: (2020)

Iron Overload in Transfusion-Dependent Indonesian Thalassemic Patients
por: Fianza, Pandji Irani, et al.
Publicado: (2021)

Transcatheter Aortic Valve Replacement (TAVR) in Thalassemic Patients
por: Mehta, Yatin, et al.
Publicado: (2022)

P1546: ACTIVATE-KIDST: MITAPIVAT IN CHILDREN WITH PYRUVATE KINASE DEFICIENCY WHO ARE REGULARLY TRANSFUSED
por: Grace, R. F., et al.
Publicado: (2022)

P1547: ACTIVATE-KIDS: MITAPIVAT IN CHILDREN WITH PYRUVATE KINASE DEFICIENCY WHO ARE NOT REGULARLY TRANSFUSED
por: Grace, R. F., et al.
Publicado: (2022)

P1565: MITAPIVAT IMPROVES INEFFECTIVE ERYTHROPOIESIS AND REDUCES IRON OVERLOAD IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY
por: van Beers, E. J., et al.
Publicado: (2022)

P1497: MITAPIVAT IMPROVES IRON OVERLOAD IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY WHO ARE REGULARLY TRANSFUSED
por: van Beers, Eduard, et al.
Publicado: (2023)

Atrial and ventricular function in thalassemic patients with supra-ventricular arrhythmias
por: Monte, Ines, et al.
Publicado: (2009)

Reticulocyte hemoglobin equivalent to detect thalassemia and thalassemic hemoglobin variants
por: Sudmann, Å A, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_83ega88fj4hrh8m0nrvm181c18